BIO-Europe 2025

Date: November 3-5, 2025                  
Frequency: once a year       
Venue: Vienna, Austria                           

Organizer: EBD GROUP, co-organized by Biotechnology

Introduction: 

The 31st European Biotechnology Congress and Exhibition 2025 (BIO-Europe 2025) takes place in Vienna from November 3-5, 2025.Every year, the biotechnology and life sciences community comes together at BIO-Europe in a different major European city to conduct business and move the industry forward. Leading biotech and biopharmaceutical companies and development teams will gather at the Munich Trade Fair Centre to realize BIO-Europe 2025.The BIO-Europe conference attracts several attendees from several organizations, including top biotech companies, pharmaceutical companies, the top 20 CROs (Contract Research Organizations) and CMOs (Contract Manufacturing Outsourcing Organizations), and 300 More than 300 research and academic institutions, such as large research laboratories, government agencies, consulting services, and experts in the field of biopharmaceuticals attend, making this event one of the largest gatherings of biopharmaceutical professionals in Europe within the industry. You can meet with drug development experts, learn more about what's going on in the industry, discuss the latest case studies as well as help accelerate your ability to scale up your next project.
Each year BIO-Europe connects industry leaders and fosters cross-sectoral partnerships between the biotech, pharmaceutical, healthcare and financial sectors. The exhibition hall will showcase curated offerings as well as an immersive conference program.BIO-Europe 2025 will shed light on important industry topics, including AI pharma, preventive medicine, big data and more.
The show also attracts high-level delegates from around the world, creating an important meeting place that maps out the key trends shaping the future of life sciences. The conference program includes high-quality debates on computer-assisted surgery, training methods, and pharmaceutical products, making it a must-attend for all players in the field.

Exhibition Highlights: 

1. Better Stand Program: In line with the Organizers' commitment to the development of the exhibition industry, they will move away from the use of disposable stands, which generate a large percentage of the show's waste. The organizers are asking exhibitors to adhere to their “Quality Stand Program” in order to provide a more convenient, better, safer and more sustainable exhibition experience for all delegates. They also encourage exhibitors to minimize the amount of handouts and materials they bring or transport to the venue.
2. Catering: The organizers aim to provide a delicious, healthy and sustainable menu for exhibitor delegates. They have partnered with a local catering company to offer seasonal and regional foods wherever possible, as well as a wide range of plant-based foods, and to accurately plan order sizes to avoid wasted pre-prepared foods. Leftover food and waste from the food production process will be used to produce biogas for municipal transportation. Ceramics and cutlery will also be available at the fairgrounds, and for disposable items they have switched to fully biodegradable materials.
3. Encouraging public transportation: The organizers are encouraging show delegates to use public transportation to get around during their participation, and they are also working closely with the local government to provide exhibitor delegates with easy access to the local transportation network.
4. Printed materials: BIO-Europe will be delivered in 100% digital format, which means that no paper products will be used on site. The organizers will have QR codes in several locations to make it easy to scan for information: this will include the event floor plan, promotional materials, conference information, partner and presentation schedules and any other relevant documents.
5. Lanyards and name tags: plain paper name tags without plastic sleeves will be used during the event. In addition, lanyards will be collected and fully recycled after the conference. The organizers encourage all attendees to place their lanyards in the recycling bins located at the entrance of the Exhibition Center after the event.
6. On-site Wellness: In addition to external activities, the organizers will set up a wellness lounge within the conference venue to provide massage services to rejuvenate your energy between collaborative sessions. “Rest and Breathe” sessions will be organized throughout the conference to give delegates time to refocus and prepare for the next event. The venue will also provide a quiet space for meditation and prayer.
7. CONFERENCE AGENDA: The goal of the show is to contribute to the sustainable development of the biotechnology industry through the events it hosts. This is reflected in the diversity of content, speakers, and opportunities for young companies, including through company showcases of all levels, geographies, and sizes, as well as opportunities for startups through the show's Startup Spotlight competition.

Facts and Figures: 

The 2024 show totaled 189 exhibitors, 3,038 company attendees; 5,700 visitors from 61 countries over the 3 days of the show; 31,000 face-to-face meetings and 4,023 license launch opportunities.
The 2023 show had 179 exhibitors, 2,971 company attendees, 74 company presentations; 5,867 visitors from 61 countries; 30,642 face-to-face meetings and 4,114 license opportunities. 

Why Exhibit: 

1. Leadership: Position your company as a leader in the biotech and pharmaceutical industries.
2. Generate new business: More than 5,000 attendees will meet with new customers and develop relationships with existing customers to further expand business opportunities in the region.
3. Increase brand exposure: BIO-Europe sponsors and exhibitors will receive significant digital and print brand exposure before, during and after the conference.
4. Increase your international presence: BIO-Europe is represented in more than 60 countries, providing your organization with multiple opportunities to reach potential customers worldwide.
5.Network with industry leaders: Connect with potential customers and partners at BIO-Europe, where 64% of attendees are senior executives or higher.
6. Maximize meetings: Maximize your meeting schedule with additional visibility in the partner system.
Products: 

Animal and Plant Pharmaceuticals, Gene/Cell Therapy, Bioinformatics, Genomics/Genetics, Medical Devices, Nanotechnology, Clinical Research and Laboratory Services, Platform Technologies, Chemistry, Stem Cell Research, Drug Delivery and Administration, Technology Transfer, Drug Development

Marketing Background: 

1. GLOBAL RECOGNITION: According to the Global Innovation Index 2023, Austria is among the top three most innovative countries in the world, making its presence felt on the global stage. Austria's pharmaceutical R&D pipeline currently includes 351 drugs in development, the fifth largest in Europe.
2. Size of the industry: Austria's life sciences industry is an important part of its economy. There are 159 pharmaceutical and biotech companies involved in 506 R&D projects in Austria, 63 of which are in clinical phases I-III.
3. Oncology and Neurology dominate: Austria's focus on oncology and neurology programs has reverberated through the biotech industry, ensuring that the future of cancer and brain disease treatments is shaped in Austria. The majority of pipeline projects in Austria (89%) are based on small molecule drugs, highlighting the focus on drug development.
4. Investment magnet: In 2021, the Austrian biotech sector attracted a record $800 million in investment, highlighting its buoyant momentum and proud potential.
5. Real-world data: more than 450 registered biobanks and 100 disease-specific, high-quality national registries cover 20-25% of the Austrian population, providing a powerful composition of rich longitudinal data to support robust real-world research, making Austria a leading source of actionable health insights.